Controlled, cross‐sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand-Reference-Cited by-同舟云学术

Controlled, cross‐sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand

Published:2014-12-02 Issue:2 Volume:21 Page:171-179
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Oldenburg J.¹,Zimmermann R.²,Katsarou O.³,Theodossiades G.⁴,Zanon E.⁵,Niemann B.¹,Kellermann E.⁶,Lundin B.⁷,

Affiliation:

1. University Clinic Bonn BonnGermany

2. Kurpfalz Hospital and Haemophilia Centre for Children and Adults Heidelberg Germany

3. Laikon General Hospital Athens Greece

4. Hippocration General Hospital Athens Greece

5. University of Padua Medical School Padua Italy

6. Bayer Vital GmbH Leverkusen Germany

7. Lund University and Skåne University Hospital Lund Sweden

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.12539

Reference36 articles.

1. National Hemophilia Foundation.Medical and Scientific Advisory Council (MASAC) recommendation regarding the need for collaboration. Document #102. Available at:http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57%26contentid=307. Accessed January 14 2014.

2. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

3. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B

4. The impact of prophylactic treatment on children with severe haemophilia

5. Haemophilia prophylaxis in young patients–a long‐term follow‐up

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A post hoc comparative real‐world analysis of HEAD‐US score for joint health assessment of patients with severe haemophilia A and B in Spain;Haemophilia;2024-01-28

2. T2 mapping magnetic resonance imaging of cartilage in hemophilia;Research and Practice in Thrombosis and Haemostasis;2023-08

3. Effectiveness of Prophylactic Coagulation Factor Replacement Therapy in Patients with Severe Hemophilia A in Taiwan – A Population-Based Study;Clinical Epidemiology;2022-12

4. The value of radiosynoviorthesis for treatment of chronic synovitis in hemophilic joint disease;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2022-11

5. The Limitations and Unmet Needs of the Five Cornerstones to Guarantee Lifelong Optimization of Prophylaxis in Hemophilia Patients;TH Open;2022-10